New Zealand markets open in 4 hours 26 minutes

Charles River Laboratories International, Inc. (CRL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
217.55+0.05 (+0.02%)
As of 01:33PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 11.46B
Enterprise value 14.19B
Trailing P/E 27.47
Forward P/E 19.42
PEG ratio (5-yr expected) 1.22
Price/sales (ttm)3.20
Price/book (mrq)4.39
Enterprise value/revenue 3.91
Enterprise value/EBITDA 16.54

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-41.20%
S&P500 52-week change 3-11.08%
52-week high 3460.21
52-week low 3203.37
50-day moving average 3236.19
200-day moving average 3324.01

Share statistics

Avg vol (3-month) 3548.89k
Avg vol (10-day) 3458.73k
Shares outstanding 550.8M
Implied shares outstanding 6N/A
Float 850.25M
% held by insiders 11.01%
% held by institutions 195.47%
Shares short (30 May 2022) 4983.83k
Short ratio (30 May 2022) 41.69
Short % of float (30 May 2022) 42.50%
Short % of shares outstanding (30 May 2022) 41.94%
Shares short (prior month 28 Apr 2022) 41.08M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 24 Dec 2021
Most-recent quarter (mrq)25 Mar 2022

Profitability

Profit margin 11.64%
Operating margin (ttm)18.13%

Management effectiveness

Return on assets (ttm)6.38%
Return on equity (ttm)17.60%

Income statement

Revenue (ttm)3.63B
Revenue per share (ttm)71.93
Quarterly revenue growth (yoy)10.80%
Gross profit (ttm)1.34B
EBITDA 937.19M
Net income avi to common (ttm)422.47M
Diluted EPS (ttm)8.20
Quarterly earnings growth (yoy)51.20%

Balance sheet

Total cash (mrq)242.93M
Total cash per share (mrq)4.78
Total debt (mrq)2.98B
Total debt/equity (mrq)111.61
Current ratio (mrq)1.34
Book value per share (mrq)51.38

Cash flow statement

Operating cash flow (ttm)693.2M
Levered free cash flow (ttm)494.16M